(
582
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Active treatment of food allergy: time for a change?
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Asthma management during the COVID-19 pandemics
-
Asthma phenotypes in children
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Biologicals in asthma
-
Biologicals in asthma – from clinical trials to real life
-
Biologicals in asthma – from clinical trials to real life
-
Breathomics in asthma diagnosis
-
Bronchiectasis and severe asthma
-
COVID-19 and virus-induced asthma in children: Asian vs western perspectives
-
Diagnosis and allocation to biologics in severe asthma – guidelines of the Polish Society of Allergology
-
Difficult to control asthma in adults
-
Difficult to control asthma in children
-
Disease burden and treatment of moderate-to-severe atopic dermatitis (AD) in children aged <12 years: results from 732 patients in the PEDISTAD observational study
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
EAACI & ERS joint symposium: new ERS clinical guidelines on diagnosis of asthma in school children
-
EAACI & KAAACI joint symposium: navigating the universe of eosinophilic inflammation in asthma
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
Electronic Health in Severe Asthma
-
Endotype-driven interventions in asthma
-
Endotype-driven treatment in chronic rhinosinusitis
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Environmental influences on allergy and asthma development
-
Environmental influences on allergy and asthma development – what is detrimental?
-
Environmental science in allergy and asthma
-
Flash Talks on asthma and biologicals
-
Flash talks on asthma
-
Flash talks on asthma II
-
Focus on Patient. Personalised therapy for severe asthma
-
How to select and follow a biological for asthma and CRSwNP
-
Immunotherapy in severe asthma (AIT)
-
Implementation of telehealth in asthma management: trials and tribulations
-
Introduction – why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
-
Late onset T2 asthma – a case study
-
Management of asthma exacerbations
-
New Epidemiologic Factors Related to allergy and asthma
-
Novel analytical tools to endotype asthma and allergic diseases
-
Novel therapeutic approaches in severe asthma
-
Novel therapeutic targets in allergic diseases and asthma – from common clues to a universal solution
-
Novel treatment approaches in urticaria
-
Occupational allergy and asthma to animals – Recent developments
-
Ophthalmic manifestations of COVID-19 and how it affected ocular allergy treatment
-
Opportunities and Obstacles to treat severe asthma with new biologics based on experiences from real world practice
-
Severe Asthma and COVID-19
-
The basics of severe asthma – biomarkers
-
The role of EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Updates in [severe] asthma in adults
-
Viral infection and asthma
-
What do clinical trials and real world tell us about allergy and asthma treatment?
-
Bacterial lysates in asthma treatment in children / Lizaty bakteryjne w astmie u dzieci.
-
Biological severe asthma treatment in Poland – pros and cons of drug programme
-
Flash talks on asthma treatment
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (56)Show Less-
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
A novel dual key solution to unlock the treatment of allergic rhinitis
-
A unified approach: Improving patient outcomes in severe asthma and comorbid eosinophilic diseases
-
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
-
Breaking new ground: A closer look at Type 2 Inflammation in pediatric asthma
-
CRSwNP, a Type 2 Inflammatory disease: Changing treatment paradigm
-
Can we break the cycle of lung function decline and asthma exacerbations driven by type 2 inflammation in asthma?
-
Championing change: Is elimination of oral corticosteroid use in asthma achievable today?
-
Childhood Asthma and the Impact of Type 2 Inflammation
-
Exploring new horizons: The future of Hereditary Angioedema treatment
-
Filling the gaps in asthma care
-
IgE in asthma and nasal polyposis: your questions answered
-
Managing severe asthma and CRSwNP: Through the lens of Type 2 Inflammation
-
Path to improving patient care in hereditary angioedema (HAE): what are the treatment goals and how can they be achieved?
-
Raising paediatric awareness through growing evidence for allergy immunotherapy – optimise the treatment of children suffering from respiratory allergy
-
Relegating OCS to last resort: Creating a paradigm shift in asthma management
-
Severe type 2 asthma: phenotypes and precision treatment for patients
-
Strengthening the immune system to reduce asthma risk: paving the way to the future?
-
TSLP: a key epithelial cytokine at the top of the asthma inflammatory cascade
-
Targeted therapy for patients with severe eosinophilic asthma – an interactive conversation with experts
-
The Evolving Evidence for the Long-Term, Prophylactic Treatment of Hereditary Angioedema Patients with Subcutaneous C1-INH
-
Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment
Show more Sponsored Symposia (20)Show Less-
-
European network for the PHenotyping of OCcupational ASthma – E-PHOCAS-Phase II 2024
-
Exercise and physical activity for asthma management: an EAACI task force position paper
-
How EAACI recommendations on ocular allergy diagnosis and treatment are applied in real life clinical practice: an international multidisciplinary survey
-
Immunometabolism in allergy and asthma – AllerIMMET
-
Joint Task Force on the role of residential greenness exposure in the multifactorial pathway towards allergy and asthma (EAACI statement)
-
Managing the upcoming increase in asthma prevalence cause by the war in Ukraine
-
Occupational Mite Allergy and Asthma (OMAA)
-
Phenotypes and endotypes of pediatric asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Public outreach for immunological mechanisms in allergies and asthma
-
The new nomenclature for allergic diseases and asthma
-
The use of omic sciences in asthma and allergy clinical practice
-
Therapeutic education for patients with asthma
-
Under- and over-diagnosis of asthma
-
Updated treatment of N-ERD: Aspirin desensitization versus Biologics: Evidence-based recommendations: To whom, When, How
-
Alpine Altitude Climate Treatment (previously High Altitude Climate Treatment HACT)
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseases
Show more Task Forces (16)Show Less-
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
-
A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
A systematic review and meta-analysis on nutritional and dietary interventions for the treatment of acute respiratory infection in pediatric patients: An EAACI taskforce
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
-
Omics technologies in allergy and asthma research: An EAACI position paper
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
-
The One Health approach for allergic diseases and asthma
-
Influenza burden, prevention, and treatment in asthma – A scoping review by the EAACI Influenza in asthma task force
Show more Position Papers (12)Show Less-
-
Association between asthma and clinical mortality/morbidity in COVID‐19 patients using clinical epidemiologic data from Korean Disease Control & Prevention
-
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
-
Association of endopeptidases, involved in SARS‐CoV‐2 infection, with microbial aggravation in sputum of severe asthma
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in Beijing
-
COVID‐19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu
-
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort
-
DGAKI statement on asthma and COVID-19
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section
-
Shielding against SARS-CoV-2 infections is not justified in children with severe asthma 
-
Severe asthma in adults does not significantly affect the outcome of COVID‐19 disease: results from the Italian Severe Asthma Registry
Show more Covid-19 (10)Show Less-
-
EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old
-
EAACI Biologicals Guidelines – Recommendations for severe asthma
-
EAACI Biologicals Guidelines – Treatment with biologicals for severe chronic rhinosinusitis with nasal polyps
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthma
-
EAACI guidelines on environmental science in allergic diseases and asthma
Show more Guidelines (4)Show Less-
Website
Collapse
-
131 genetic loci highlight immunological pathways and tissues in asthma and nasal polyposis
-
17q21 locus rs7216389 polymorphism and asthma risk: a meta-analysis
-
A 12 months real-life prospective study of lung function in patients with severe eosinophilic asthma undergoing therapy with ics/laba, lama, and anti IL5/5R monoclonal antibody
-
A Phase 3 Open-Label Trial-In-Progress Evaluating Garadacimab For Prophylactic Treatment Of Pediatric Patients (Aged 2–11 Years) With Hereditary Angioedema
-
A Semi-Quantitative Evaluation of Leniolisib Treatment Response Through a Physician Survey of Patients with Activated PI3Kδ Syndrome (APDS) Under an Early Access Programme (EAP)
-
A Study Conducted in the Environmental Exposure Chamber (EEC) to Assess Onset of Action of Combination of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Dymista) in the Treatment of Allergic Rhinitis Symptoms Compared to Placebo
-
A case of life-threatening asthma triggered by mood disorder and sexual abuse
-
A possible integrated mind-body approach to CSU treatment
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
A proof-of-concept study on an artificial intelligence model for biological therapy decision-making in severe asthma
-
AI-derived trajectories of wheezing and asthma in children: a systematic review
-
Abatacept (cytotoxic T lymphocyte antigen 4-fragment crystallizable) treatment suppressed disease activity in a mouse model of Eosinophilic CRS
-
Accuracy of changes in fractional exhaled nitric oxide for diagnosing occupational asthma
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Advances in Chronic Urticaria treatment
-
Advances in LTP allergy: mechanisms, diagnosis, and treatment
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Advancing Asthma Diagnosis: Integrating Exhaled Biomarkers and Deep Neural Networks (DNNs) in a POC Breath Test
-
Adverse reactions to biologicals in severe asthma
-
Algorithm for preventative treatment of viral infections reverses the negative impact of atopic traits on day-care absenteeism of preschool children
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergic asthma
-
Allergic asthma – a challenge no more
-
Allergy asthma and a sport
-
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
-
Analysis of exacerbating factors of pediatric asthma before and after the COVID19 pandemic
-
Anaphylaxis during OIT and its impact on treatment adherence: a monocentric retrospective study
-
Anti IgE for the treatment of chronic urticarial
-
Anxiety Associated with On-Demand Treatment for Hereditary Angioedema Attacks
-
Application of Smart Wearable Devices in Management of Asthma
-
Apply cluster analysis and machine learning to identify phenotypes of work-related asthma
-
Approaching CRSwNP and asthma with biologicals – RWE data
-
Assessing Disease Activity to Better Define On-Treatment Clinical Remission in Pediatric Severe Asthma
-
Assessing specific pro-catabolic mediators (SPMs) as Innovative Biomarkers in Allergen Immunotherapy: Monitoring Treatment Efficacy
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between obesity and repeated epinephrine administration for treatment of anaphylaxis: a Taiwan tertiary hospital experience from 2001 to 2020
-
Asthma
-
Asthma & Biologicals
-
Asthma 1
-
Asthma 2
-
Asthma 3
-
Asthma 4
-
Asthma 5
-
Asthma 6
-
Asthma 7
-
Asthma 8
-
Asthma 9
-
Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence – Based Risk Prediction
-
Asthma Right Care – the growth of the social movement to reduce reliance on episodic care and to increase long term safe and person-centred care
-
Asthma and Climate Change: A Five Year Study of Camp Wheez
-
Asthma and comorbidities
-
Asthma and nutrition
-
Asthma endotypes in the era of data science boom!
-
Asthma exacerbations and death after recovery from COVID-19: A nationwide long-term follow-up study
-
Asthma exacerbations in the pediatric emergency area: evaluation and prospects for improvement of pre-hospital care
-
Asthma in Brazilian children and adolescents
-
Asthma in the Intermediate/Intensive Care of a Central Hospital
-
Asthma is associated with increased sickness absence among young adults
-
Asthma phenotype markers did not affect allergen immunotherapy effectiveness
-
Asthma remission: what is it and how can it be achieved?
-
Asthma response in patients with allergic rhinoconjunctivitis to grass pollen using an environmental exposure chamber
-
AstraZeneca – Transforming severe asthma respiratory care: the clinical experience
-
At the core of allergy and asthma pathology: exploring the connection between airway epithelium and effector cells
-
Balancing HAE and pregnancy: treatment recommendations and approaches
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Baseline disease burden in severe asthma patients treated with biologics, and eligible but not treated: Spanish patients in the ISAR Registry
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Belimumab treatment rapidly restores B cell homeostasis and reduces atypical T-bet+ B cell expansion in patients with systemic lupus erythematosus disease
-
Benralizumab effectiveness in severe eosinophilic asthma patients from Central Eastern Europe and Baltics: BREEZE study
-
Best tools for allergy and asthma translational research
-
Biologics have Solved the Problem of Type 2 Asthma
-
Brazilian Anaphylaxis Registry: Main triggers, clinical manifestations and treatment
-
Breast-feeding is inversely associated with asthma and IgE sensitisation up to young adulthood
-
Briquilimab, an Anti-Human CD117 Antibody, Effectively Treats Cockroach Allergen-Induced Asthma Model Elicited in Mice Expressing Chimeric Human/Mouse CD117
-
Bronchiolitis and future risks for childhood asthma
-
Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function
-
Case report of an occupational disease in a veterinarian with allergic asthma
-
Causes of death in patients diagnosed with severe asthma in our area- 10 years observational study
-
Challenges in the treatment of CRSwNP with biologics
-
Changes in the awareness on anaphylaxis and asthma exacerbation: Education for 119 emergency department paramedics in Korea
-
Characterization of patients with Eosinophilic Esophagitis and response to first-line treatment in a Portuguese Immunoallergology Department
-
Chemical product exposure in professional cleaners and its relationship with occupational asthma
-
Childhood asthma and allergy is related to accelerated epigenetic aging in the LISA birth cohort
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Clinical Characteristics of Patients with Severe Asthma by Different Elevated Biomarkers Classifications: Patients from Spain in the ISAR Registry
-
Clinical evaluation of an immunotherapy treatment with Vespa velutina venom in allergic patients. Results from a prospective multicenter Study: W-STING Study
-
Clinical experience with newer systemic treatment for moderate to severe atopic dermatitis in children and adolescents: a single-centre study
-
Clinical implications of biologic therapies in comorbid severe asthma and CRSwNP
-
Clinical outcomes used in allergen immunotherapy in allergic asthma in the era of Data Science
-
Clinical profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Clinical trials on Asthma and Rhinitis
-
Closing Gaps in HAE Management: Addressing Delays in On-Demand Treatment
-
Comparative Gene Expression Analysis in Blood Samples and Nasal Polyps during Dupilumab Treatment for CRSwNP
-
Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids Among Asthma Patients
-
Comprehensive Analysis Of Pediatric ICU Admissions For Severe Acute Asthma Over A Decade
-
Correlation between Fractional exhaled nitric oxide and pulmonary function test in children with asthma
-
CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment
-
Cracking the code on asthma prevention
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers
-
Demographic Features Of Allergic Rhinitis Patients and Effect of Nasal Corticosteroid Treatment
-
Diagnosing Asthma with an Exhaled Breath Test at the Point of Care (POC)
-
Diagnosis and Treatment of Allergies at ENT Department of General Hospital of Nafplio, Greece
-
Diagnosis of allergic asthma
-
Differential study of whole genome expression profiles of peripheral blood mononuclear cells in children with dust mite specific immunotherapy for asthma
-
Donidalorsen for the treatment of hereditary angioedema: Results from a phase 3, randomised, placebo-controlled trial
-
Dose reduction of dupilumab at 24 months of treatment in patients with controlled atopic dermatitis
-
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
-
Dupilumab Reduces Systemic Corticosteroids in Children With Uncontrolled Moderate-to-Severe Asthma Regardless of Exacerbation History
-
Dupilumab as effective treatment for chronic pruritus: a case report
-
Dupilumab for Treatment of Eosinophilic Gastrointestinal Disease in children
-
Dupilumab treatment effectively reduces nasal type 2 cytokine production following acetylsalicylic acid provocation in N-ERD patients
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
EAACI & AAAAI Joint Symposium : The Microbiome: A target for treatment and/or prevention of allergic disease
-
EAACI & IPCRG Joint Symposium : Improving the Delivery of Person-centred asthma care in global primary care
-
EAACI nomenclature for allergy and asthma
-
Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps
-
Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp
-
Effect of baseline long-acting muscarinic antagonist (LAMA) use on inhaled corticosteroid dose reduction in patients with severe eosinophilic asthma treated with benralizumab: SHAMAL post-hoc analysis
-
Efficacy and Safety of 1-Year Dupilumab Treatment in Children Aged 6-11 years with Moderate-to-Severe Atopic Dermatitis in South Korea: Multicenter Prospective Observational Study
-
Efficacy and Safety of the Oral Bradykinin B2 Receptor Antagonist Deucrictibant Immediate-Release Capsule in Treatment of Hereditary Angioedema Attacks: RAPIDe-3 Phase 3 Trial Design
-
Efficacy of Dupilumab in patients over 50 years of age with severe asthma
-
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
-
Efficacy of Rilzabrutinib on Asthma Control: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Efficacy of Rilzabrutinib on Asthma Quality of Life: Results From a Double-Blind Placebo-Controlled Phase 2 Study
-
Emergency treatment of anaphylaxis
-
Emerging therapies and approaches for achieving remission in severe asthma
-
Empowering Patients: Innovations in Allergic Rhinoconjuntivitis treatment
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
EoE treatment
-
Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab
-
Epigenome-wide association study of asthma exacerbations in European populations
-
Evaluating the Impact of Leniolisib Treatment on Symptoms and Health-Related Quality of Life (HRQoL) in Activated PI3Kδ Syndrome (APDS)
-
Evaluation of patients’ expectation and benefits of sublingual Named-Patient Products in the treatment of allergic respiratory diseases: the French ERAPP prospective cohort study
-
Evaluation of remission of Severe Asthma treated with monoclonal antibodies according to different definitions: a single center cohort
-
Evaluation of the Pediatric Patients with Severe Eosinophilic Asthma Treated with Mepolizumab
-
Evolution of health-related quality of life and disease control during the first year of Lanadelumab treatment in Romanian patients with Hereditary Angioedema due to C1-inhibitor deficiency
-
Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Exosomal Signaling and Mitochondrial Transfer Reprograms T Helper Cell Function in Human Asthma
-
Exploring the Potential of Serum Periostin and YKL-40 as Airway Remodeling Markers for Airway Hyperresponsiveness in Pediatric Asthma
-
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
-
Flash talks on Asthma
-
Flash talks on Asthma
-
Flash talks on Pediatric Asthma
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Frequency of asthma exacerbations in Mexican patients with Vitamin D insufficiency/deficiency and dyslipidemia
-
From suspected poorly controlled asthma to allergic bronchopulmonary aspergillosis
-
GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Genetic polymorphisms associated with the development of asthma in the Kazakh population
-
Genome-wide association study identifies CACNA2D3 associated with asthma and atopic dermatitis multimorbidity in children
-
Global Initiative for Asthma (GINA) Guidelines
-
Group A – Asthma
-
Gut Microbiota and Phenotypes of Childhood Asthma
-
Healthcare Provider Burden associated with the treatment of attacks in patients with hereditary angioedema in Latin America: A Pilot Study
-
Hereditary Angioedema Attack Diary Determination of the Effect of Mobile Application on Patients’ Quality of Life and Treatment Compliance Level
-
Home-based introduction of egg protein in paediatric IgE-mediated Egg allergy – a review of treatment strategy 2011-2021 at Midland Regional Hospital Portlaoise
-
Hot Topics in Pediatric Asthma
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
How to deal with insufficient response to biologic treatment in CRSwNP
-
How to manage treatment of a red eye
-
Human milk oligosaccharides 3’SL and 6’SL suppress airway hyperreactivity, while only 3’SL also reduces airway inflammation in a murine allergic asthma model
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
IL-13 and airway calibre codetermine exhaled nitric oxide levels in type-2 asthma patients
-
ILIT.NU: Titration of Allergen for Treatment of Grass Pollen Induced Rhinoconjunctivitis with Intralymphatic Immunotherapy
-
Identifying Key Outcomes in the Treatment of Activated PI3K Delta Syndrome: Results From a Modified Delphi Panel
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immuno-metabolic reprogramming of bronchial epithelium in asthma
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Immunodeficiency spectrum in patients with severe asthma receiving biologicals
-
Immunological changes induced by a salsola kaly extract in patients with allergic rhinitis or rhinitis and asthma
-
Impact of Asthma on Hospitalization and Antibiotic Courses in Common Variable Immunodeficiency Respiratory Infections
-
Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis
-
Impact of liquid sublingual immunotherapy with mixed pollen allergens on asthma prevention in polyallergic patients: results from the real-world EfficAPSI study
-
Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes
-
Indirect case matched comparison of dupilumab versus benralizumab on mannitol airway hyperresponsiveness in type 2 high severe asthma
-
Individualized treatment strategy in our unit in patients with predominantly Api m 10 sensitization profile
-
Infective asthma exacerbations in severe asthmatic patients receiving biological drugs
-
Inflammatory and Oxidative Stress Markers in Serum, Urine and Exhaled Breath Condensate: Relationship between Asthma and Obesity in Children
-
Inflammatory cytokine-mediated airway remodeling in asthma
-
Influence of selected cytokines and chemokines on the ventilation efficiency in spirometric examination, in patients with asthma post-COVID-19
-
Inhaled corticosteroid-related neuropsychiatric side effects in children with asthma
-
Insights from Benralizumab Treatment
-
Integrating Breathomics with CPET: A Breath-Taking Approach to Exercise-Induced Asthma Monitoring
-
Interindividual variability in serum concentration of montelukast and metabolites in asthma patients
-
International Eczema Council symposium : Safety of JAK inhibitors in the treatment of inflammatory skin diseases
-
Investigating the Role of TBXA2R rs4523 Gene Polymorphism Associated with Asthma among Population of West Bengal, India
-
Investigation of the predictors of asthma phenotypes (atopic and non-atopic asthma) using machine learning and traditional statistical techniques
-
Involvement of Janus kinase (JAK)-dependent Bcl-xL overexpression in steroid resistance of group 2 innate lymphoid cells (ILC2s) in asthma
-
Is Mediterranean Diet Best for Asthma Prevention?
-
Levels of total IgE vs. specific IgE during childhood for defining and predicting T2-high asthma
-
Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study
-
Long-Term Efficacy of Mepolizumab at 5 Years in Patients with Severe Asthma
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Long-term dupilumab effect on lung function in subgroups of pediatric patients with uncontrolled asthma
-
Long-term outcome of work-related asthma
-
Long-term safety of donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 open-label extension OASISplus study
-
Low education level, occupational exposure and no medication use increase the risk of uncontrolled asthma in Chinese patients: findings from baseline data of a multi-centre, single-arm study (CARE FOR ALL)
-
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
-
Lung Function Responder Rates in the VOYAGE study in Children with Moderate-to-Severe Type 2 Asthma Receiving Dupilumab at Week 52
-
MY006: anti-allergen multispecific antibody for the treatment of peanut allergy
-
MY010: anti-allergen antibodies for the treatment of Fagales pollen allergy
-
Management of allergic asthma
-
Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: a prospective birth cohort study
-
Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma
-
Measuring adherence to inhaled asthma controller medication
-
Mechanisms and Predictors of Response or Failure to Biologic Therapies in Asthma and Allergy
-
Mepolizumab simultaneously improves clinical outcomes in severe CRSwNP and asthma in the SYNAPSE study: Focus on global airway disease
-
Meta-analysis of primary endpoint of PQ Grass field studies with optimized dose and treatment regimen of PQ Grass
-
Mid-Term Impact of Non-Pharmaceutical Interventions on the Epidemiology of Hospitalizations for Severe Asthma Exacerbation in Children : A Time-Series Analysis
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Model-based machine learning to understand progression of asthma through life-course
-
Moderate-High Blood Eosinophilia Is Associated with Increased Hospitalization and Other Asthma Comorbidities
-
Modification of biologic treatment in Super-responders
-
Molecular allergen sensitizations drive phenotypes of severe asthma in children: evidence from a megacity cohort (SAMP)
-
Monitoring Patients with Severe Eosinophilic Asthma Receiving Benralizumab in Allergy Centers in Greece for 8-12 months – REALISM-A Study (gReek rEAl Life regIStry of benralizuMab among Allergists)
-
Monocyte chemotactic factors in the airways of patients with asthma after an allergen challenge
-
Nasal obstruction in children: diagnosis and treatment
-
Navigating the asthma maze in children: insights into phenotypes, innovative treatments, and preventive measures
-
New treatment options in childhood atopic dermatitis
-
Novel Treatment Approaches for Patients with SM and Mediator-Related Symptoms
-
Novel treatment approaches in AR: AIT, Biolgicis or the combination?
-
Novelties in asthma Biomarkers and immunomodulatory pathways
-
OAS3: ENT, asthma and respiratory allergy
-
Obesity Modified the Genetic Effect on Risk of Asthma: A Genome-wide Association Study of Adult Asthma
-
Omalizumab Combined Chinese Traditional Medicine in a Complicated Severe Asthma after Bronchial Thermoplasty
-
Opening and Introductions: Challenges with Delays in On-demand Treatment
-
Optimising asthma management in children
-
Optimising support for patients with asthma – a primary care model
-
Oral Sebetralstat for On-demand Treatment of Hereditary Angioedema: Phase 3 KONFIDENT Trial Results
-
Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach
-
OverSEA: European Delphi Consensus Study on Best Practices for patients with Severe Eosinophilic Asthma and comorbid CRSwNP
-
Overview of Asthma On-Treatment Clinical Remission Data
-
PDS9: Asthma
-
Parasitic Infection as a risk factor for Childhood Asthma in Upper Egypt
-
Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks
-
Patients With Moderate-to-Severe Asthma Treated With Dupilumab Are More Likely to Meet Clinical Remission Criteria: Results From the VESTIGE Trial
-
Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens
-
Pectin dietary supplementation as potential treatment of lipid transfer protein allergy
-
Perceived Impact and Awareness of Climate Change among Climate-Vulnerable Adults with Asthma
-
Perseverance in Asthma Education: Controlling Frequent Wheezing in a schoolgirl
-
Personalized application of Biologics in pediatric allergy and asthma
-
Polistes gallicus: an alternative treatment for European paper wasp venom allergic patients?
-
Practical Guide to Biomarker-Driven Pediatric Asthma Management
-
Precision treatment for allergic diseases
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictors of Exacerbation-Prone Asthma in children: comorbidities and T2 Biomarkers with allergy sensitization
-
Predictors of Treatment Response to Biological Therapy in Patients with Severe Asthma: Insights from Induced Sputum Analysis
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Predictors of biological therapy in severe asthma patients. An ambispective study from the BIOBADALER consortium
-
Preimplantation genetic testing in hereditary angioedema: prevention outperforms treatment
-
Prevalence and causes of AR and asthma in Mongolia
-
Prevalence and impact of allergic comorbidities in patients with severe atopic dermatitis in treatment with Dupilumab
-
Prevalence of asthma as comorbidity in uncontrolled CRSwNP prior to endoscopic sinus surgery – a cross-sectional study
-
Prevalence of severe fatigue and its contributing factors in patients with severe asthma
-
Prevention of allergic asthma
-
Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype
-
Probiotics Supplementation on mitigating adverse effects of Phthalate-Induced Asthma
-
Progression of Underlying Disease in Pediatric Severe Asthma
-
Progressive increase of the intervals between omalizumab administration in severe asthma
-
Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients with Hereditary Angioedema
-
Proposal of an algorithm for asthma diagnosis using molecular biomarkers
-
Psoriasis, allergic rhinitis, biological treatment and immunological therapy – a case report
-
RHINA : What can we learn from the asthma guidelines
-
Raising the Bar in Asthma Management: On-Treatment Clinical Remission
-
Rationale and Design of the ALPHA-SOLAR Clinical Trial of STAR-0215 for the Treatment of Hereditary Angioedema (HAE)
-
Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab
-
Real-life data analysis of severe asthma patients undergoing biologic therapy: OCS consumption and respiratory function evaluation
-
Real-life efficacy of dupilumab in patients with asthma phenotype overlap- data from a tertiary pulmonary centre
-
Real-life experience and the safety of Immunobiologicals in the treatment of immunoallergic diseases
-
Real-world effectiveness of biologics in patients with severe asthma: analysis of the Korean Severe Asthma Registry (KoSAR)
-
Real-world efficacy of dupilumab as a second-line treatment in severe asthma- data from a tertiary pulmonary centre
-
Reduced Allergic Asthma By Soy And Its Potential Mechanism Via Plasminogen Activator Inhibitor-1
-
Regulatory Perspectives on Food Allergy Treatment and Research
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relationship Between Disease Control, Oxidative Stress And Diet In Adolescent Asthma Patients
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Relevance of IL-17-associated immune pathways and CXCL10 expression in severe childhood asthma
-
Respiratory muscle functions in asthma
-
Response to benralizumab in severe vernal keratoconjunctivitis after treatment failure with omalizumab
-
Retrospective analysis of quantitative CT characteristics of patients with severe asthma treated with biological agents: KoSAR registry
-
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
-
Risk stratification in primary care: how to use data to identify people in primary care at risk of harm due to under or over treatment and to prioritise their care
-
Role of The Gut Microbiome in Food Allergy: Potential For Prevention and Treatment
-
Role of the single nucleotide variants of filaggrin, thymic stromal lymphopoietin and orsomucoid-1-like protein 3 in the development of atopic bronchial asthma phenotypes in children
-
Root and branch of childhood asthma management
-
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
-
SQ house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet is well-tolerated in children with inadequately controlled HDM allergic asthma
-
Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract
-
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
-
Sanofi : What’s New in CRSwNP? Real-Life Experiences and Current Treatment Goals
-
Sebetralstat as Oral On-demand Treatment for Hereditary Angioedema: Interim Analysis of Demographics and Attack Characteristics from the Open-label KONFIDENT-S Trial
-
Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study
-
Serial fractional exhaled nitric oxide measurements at and off work: usefulness for diagnosis and tertiary prevention of occupational asthma
-
Serum Levels of Cytokine in Individuals with Severe Asthma with Obesity
-
Serum Periostin Level Predicted Length of Hospital Stay in Patients with Allergic Asthma
-
Severe Asthma and Obesity: A retrospective study
-
Severe Eosinophilic Asthma later recognized as EGPA treated with Benralizumab
-
Severe asthma in pediatrics and Dupilumab after failure with Omalizumab
-
Severe asthma or COPD with eosinophilic inflammation? – from uncertainty to remission under anti-IL-5R therapy
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Sex differences in childhood asthma are driven by a T2-high phenotype and mediated through sex-hormone metabolites
-
Stability of steroid-dependent severe asthma during 5-year follow-up
-
Sub-study from the EAACI allergy educational needs in Primary Care Paediatricians to gauge association of GDP impact on differences of allergy diagnosis and treatment healthcare
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is safe in a pre/co-seasonal treatment regimen – a subgroup comparison
-
Successful Treatment of Post-Orgasmic Illness Syndrome with Omalizumab: A Report on Two Case
-
Successful treatment of lichen amyloidosis with dupilumab treatment: a case report
-
Successful treatment of upadacitinib in prurigo nodularis: a case report and review of the literature
-
Successfully managing severe asthma
-
Sympout study: Effectiveness of a sublingual allergen extract in liquid formulation standardized in TBU/ml in patients with bronchial asthma due to house dust mites or pollens
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
Systemic Treatment of Atopic Dermatitis in Pregnancy: The Physician’s Perspective
-
T2 inflammatory profile of 457 Latin-American severe asthma patients in Mexico: differences between those who are and those who are not on biologics (OMA, DUPI, anti-IL5)
-
Targeting TSLP in severe asthma
-
Tests to Diagnose Asthma
-
The Effect of Japanese cedar pollen SLIT-tablets increases with years of treatment
-
The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials
-
The Eosinophil in Obstructive Airway Disease – Beyond Asthma
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The Impact of Excess Weight and Obesity on Asthma Control in a Pediatric Population
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study
-
The burden of allergic diseases and asthma – results from the HEAD registry
-
The dynein adaptor Hook2 as microtubule-based transport and anchors for organelles is involved in asthma pathogenesis
-
The effectiveness and safety of Abrocitinib treatment for severe atopic dermatitis in the real-world data in Turkey
-
The efficacy in treatment of facial melasma combined with thulium 1927-nm fractional laser and topical H2R antagonist: a split-face, single-blind study
-
The evolution of HAE: Classification and goals of treatment
-
The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study
-
The impact of Type 2- targeted biological therapies on persistent cough in adults with cough variant- or cough predominant asthma
-
The impact of asthma and mental health condition multimorbidity in national samples of Canadian children
-
The impact of second-hand exposure to e-cigarette on asthma exacerbations in the pediatric population
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The m6A demethylase FTO mediates type 2 inflammation in asthma by regulating STAT6 mRNA stability
-
The new nomenclature for asthma and allergy
-
The parasympathetic nervous system plays a key role in control and stress in patients with asthma
-
The potential of anti-infectives and immunomodulators in pediatric asthma
-
The puzzling journey of asthma diagnosis – the IPCRG’s new educational approach.
-
The relevance of IL-5 biology in severe asthma
-
The significance of FeNO test in patients with different asthma endotypes
-
The triple type 2 signature is associated to asthma severity and comorbidity with CRS
-
Towards a Treat to Target approach in asthma: Asthma remission
-
Transforming severe asthma respiratory care: the clinical experience
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare
-
Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients
-
Treatment of atopic dermatitis patients with dupilumab restores functional responses of circulating skin-homing CD4+ T and B cells
-
Treatment of refractory urticaria in children
-
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
-
Triggers and Mechanisms of Asthma Exacerbations: One Outcome, Many Paths?
-
Tumor necrosis factor-alpha in allergic inflammation in overweight children with asthma
-
Type 2-high airway inflammation in childhood asthma distinguishes a more severe phenotype
-
Understanding treatment switching patterns and continuation rates for patients with hereditary angioedema receiving lanadelumab: analysis of real-world data
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique effect of aspirin on bronchial 15-oxo-ETE levels in patients with asthma and aspirin hypersensitivity
-
Unique role of Candida albicans sensitization in management of asthma patients living underground during military operations in Ukraine
-
Urticaria in the context of treatment with trimethoprim/sulfamethoxazole due to trimethoprim sensitization
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Use of biologics in severe uncontrolled asthma at National Institute of Pediatrics 2020-2023
-
Variables predicting clinical remission among adults with severe asthma treated with biologic agents
-
Vitamin D3 deficiency is more common in children with asthma than in children with other allergic diseases
-
Voice biomarkers: a new tool for asthma management
-
Weighing the Pros and Cons of systemic steroids in CRS treatment
-
What are the predictors of asthma remission and what can we modify?
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
What is the optimal time for diagnosis and treatment of peanut allergy in children?
-
What’s new in CRSwNP? Real-Life experiences and current treatment goals
-
When and how it starts: unveiling the early development of asthma in preschool years
-
Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis
-
Allergy and Asthma – Session 1: Diagnosing Asthma
-
Allergy and Asthma – Session 2: Precision medicine in pediatric asthma
-
Association of asthma severity with high sensitivity C-reactive protein (hsCRP) in the all-age asthma cohort ALLIANCE
-
Baseline Characteristics of Patients with Severe Asthma in Spain according to biological treatment use: BREATHE study
-
Biomarker-guided approach for treatment of preschool asthma
-
Characterization of Patients With Asthma Initiating Dupilumab Treatment in a Real-World Setting: The RAPID Registry
-
Clinical effects of dupilumab in patients with rhinosinusitis, nasal polyposis, and severe uncontrolled asthma with t2 phenotype, after 12 months of treatment
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Elevating patient treatment outcomes in Severe Asthma
-
Elevating patient treatment outcomes in Severe Asthma & comorbid CRSwNP
-
Eosinophilia over dupilumab treatment in asthma patients: a multicentric retrospective study
-
GSK – Elevating patient treatment outcomes in severe asthma and CRSwNP
-
Health Care Situation in the Treatment of Uncontrolled GINA 4/5 Asthma Patients in Germany: 2019 vs. 2022
-
Impact of liquid sublingual immunotherapy on asthma worsening prevention: GINA treatment stepping up results from the real-world EfficAPSI study
-
KalVista Pharmaceuticals – Closing Gaps in HAE Management: Addressing Treatment Delays in On-Demand Treatment
-
Monitoring for early warning signs of asthma attacks and response to treatment with oral corticosteroids using the Albus Home contactless monitoring system
-
Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years
-
Self-reported treatment preferences of patients switching from prior prophylactic therapies to donidalorsen for the treatment of hereditary angioedema: Results from the phase 3 OASISplus study
-
Serum cytokine profiles of pediatric normal weight asthma and overweight/obese asthma and their correlation with pulmonary function indices
-
Severe asthma and sleep disorders: a Severe Asthma Network Italy (SANI) analysis
-
Successful treatment of severe asthma after switch of biologics. A case report
-
Sympout study: Need of medication for symptom control in patients with rhinitis and/or bronchial asthma due to house dust mites or pollens in treatment with sublingual immunotherapy in a standardized liquid formulation in TBU/ml
-
Targeted drug-induced apoptosis in key cellular mediators of allergic asthma as a new treatment strategy
-
The Use of Long-acting Muscarinic Antagonist (LAMA) in the Treatment of Asthma: A Tertiary Asthma Center Experience
-
The effect of tezepelumab treatment on the incidence of asthma exacerbations co-occurring with acute respiratory illnesses attributed to infections: results from a pooled analysis of the PATHWAY and NAVIGATOR studies
-
Toward Optimal disease control: impact of maintenance inhaler therapy and device transition in severe asthma patients undergoing monoclonal antibody treatment
-
Treatment of severe asthma (update)
-
Asthma control, lung function, and quality of life in pediatric patients with severe asthma undergoing biological treatment
-
Characteristics and Asthma Control Status of Severe Asthma Patients in the Korean Severe Asthma Registry-2 (KoSAR-2)
-
Characteristics of asthma phenotypes: Does coexistence of allergic and eosinophilic asthma increase asthma severity?
-
Decoding Asthma Therapies: Transcriptomic differences between benralizumab and mepolizumab treatment in patients with severe eosinophilic asthma
-
Investigation Of Treatment Responses And Clinical Characteristics Of Patients With The Late-Onset Asthma Phenotype Under Biological Treatment
-
Patients with severe eosinophilic asthma starting anti-IL5 treatment after 2018 have better preserved lung function compared to the patients who started treatment earlier
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
Show more Sessions (412)Show Less-
-
Albania – Albanian Society of Allergy, Asthma and Clinical Immunology (ASAACI)
-
Asia Pacific – Asia Pacific Association of Allergy Asthma and Clinical Immunology (APAAACI)
-
Cuba – Cuban Society of Allergy, Asthma and Clinical Immunology (CSAACI)
-
Iran – Iranian Society of Asthma and Allergy
-
Saudi Arabia – Saudi Allergy Asthma & Immunology Society (SAAIS)
-
Spain – Spanish Pediatric Society of Clinical Immunology, Allergy and Asthma (SEICAP)
-
Turkey – Academy of Pediatric Allergy and Asthma (CAAAD)
Show more Member societies (5)Show Less-
-
Allergy diagnosis and treatment in Primary Care: Major EAACI-PCPs-TF survey launched
-
Cover the Latest Developments in Allergy and Asthma at the EAACI Congress 2024 in Valencia, Spain
-
Launch of the PAI Virtual Issue on Asthma & Environment
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma Management
Show more News (2)Show Less-